1,720,960 research outputs found
Increased plasma levels of nerve growth factor (NGF) in vernal keratoconjunctivitis (VKC) and its relationship to conjunctival mast cells
L'autoregolazione ciliare nei soggetti affetti da glaucoma a bassa pressione. indagine preliminare
Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis
The purpose of the study is to evaluate in a double-blind, randomized study the efficacy of lodoxamide tromethamine 0.1% versus placebo
Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis
La cilio-anemizzazione associata alla ciclo-criocoagulazione nel trattamento dei glaucomi refrattari
Studio clinico controllato sull'efficacia del Metipranololo collirio sul coefficiente di deflusso trabecolare. Indagine comparativa.
Going Beyond Counting First Authors in Author Co-citation Analysis
The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Studio clinico cross-over randomizzato sulle modificazioni indotte da farmaci betabloccanti (metipranololo 0.3%, timololo 0.5%, betaxololo 0.5%) sul flusso ematico oculare pulsatile
- …
